Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphoma

about

Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphoma

Item

http://www.wikidata.org/entity/Q36336614

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Controversies and recent advan ...... ollicular non-hodgkin lymphoma

@ast

Controversies and recent advan ...... ollicular non-hodgkin lymphoma

@en

type

Item

label

Controversies and recent advan ...... ollicular non-hodgkin lymphoma

@ast

Controversies and recent advan ...... ollicular non-hodgkin lymphoma

@en

prefLabel

Controversies and recent advan ...... ollicular non-hodgkin lymphoma

@ast

Controversies and recent advan ...... ollicular non-hodgkin lymphoma

@en

P1476

Controversies and recent advan ...... ollicular non-hodgkin lymphoma

@en

P2093

Abraham S Kanate

http://www.w3.org/2001/XMLSchema#string

Mehdi Hamadani

http://www.w3.org/2001/XMLSchema#string

Mohamed A Kharfan-Dabaja

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults

High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.

Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.

Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.

P304

897215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/897215

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232700743

http://www.w3.org/2001/XMLSchema#string

P698

23097707

http://www.w3.org/2001/XMLSchema#string

P932

3477524

http://www.w3.org/2001/XMLSchema#string